ABINGDON HEALTH PLC Logo

ABINGDON HEALTH PLC

A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.

ABDX | IL

Overview

Corporate Details

ISIN(s):
GB00BLB79S77 (+2 more)
LEI:
213800XFI4WV3FBILO20
Country:
United Kingdom
Address:
YORK BIOTECH CAMPUS, YO41 1LZ YORK
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Abingdon Health PLC is a contract development and manufacturing organization (CDMO) specializing in lateral flow rapid tests. The company provides comprehensive, end-to-end services supporting clients from initial concept through to commercial success. Core offerings include assay development, scale-up, technical transfer, high-volume manufacturing, regulatory consultancy, and commercialization support. The company serves a diverse range of sectors, including clinical diagnostics, animal health, and plant health. In addition to its contract services, Abingdon Health also develops, manufactures, and distributes its own portfolio of branded lateral flow products to a global network of consumers, retailers, and distributors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-04 08:45
Remuneration Information
Vesting and Award of Options under LTIP
English 87.4 KB
2025-12-02 16:20
Major Shareholding Notification
Holding(s) in Company
English 119.0 KB
2025-11-14 15:10
Pre-Annual General Meeting Information
Notice of AGM & Publication of 2025 Annual Report
English 15.7 KB
2025-11-11 08:20
Annual Report
Final Results
English 305.0 KB
2025-11-10 08:10
Regulatory Filings
c.US$2m multiplex diagnostic test contract win
English 17.6 KB
2025-11-06 08:30
Environmental & Social Information
Launch of seaweed-based lateral flow housings
English 22.3 KB
2025-11-04 18:10
Major Shareholding Notification
Holding(s) in Company
English 50.5 KB
2025-11-04 08:25
Major Shareholding Notification
Holding(s) in Company
English 52.1 KB
2025-11-03 08:30
Report Publication Announcement
Notice of Results
English 17.3 KB
2025-10-30 10:43
AGM Information
Result of Meeting and TVR
English 61.1 KB
2025-10-17 08:00
Share Issue/Capital Change
Result of Retail Offer
English 24.5 KB
2025-10-14 08:58
Share Issue/Capital Change
Launch of Retail Offer
English 50.1 KB
2025-10-14 08:47
Share Issue/Capital Change
Result of Placing and Notice of GM
English 30.1 KB
2025-10-13 18:04
Share Issue/Capital Change
Proposed Placing and Retail Offer
English 214.5 KB
2025-08-14 19:01
Director's Dealing
Director/PDMR Shareholding
English 26.1 KB

Automate Your Workflow. Get a real-time feed of all ABINGDON HEALTH PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ABINGDON HEALTH PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ABINGDON HEALTH PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ACHIEVE LIFE SCIENCES, INC. Logo
Developing cytisinicline, a plant-based treatment for smoking cessation and nicotine addiction.
United States of America
ACHV
AC Immune SA Logo
Developing precision medicine to diagnose, treat, and prevent neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
A clinical-stage biopharma developing novel drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Develops precision cancer therapies by matching patients to drugs using its proteomics platform.
United States of America
ACRV
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Develops targeted radiotherapies for advanced cancers like AML and prostate cancer.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing a novel GSK-3 inhibitor for hard-to-treat cancers.
United States of America
ACTU
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing an antibody therapy for Alzheimer's by targeting toxic AβOs.
United States of America
ABOS
Acurx Pharmaceuticals, Inc. Logo
Developing a new class of antibiotics to treat priority Gram-positive bacterial infections.
United States of America
ACXP

Talk to a Data Expert

Have a question? We'll get back to you promptly.